NCT06409195 2024-05-10A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin CancersDermBiont, Inc.Phase 2 Unknown50 enrolled